NEXVIAZYME Trademark Information

Trademark by GENZYME CORPORATION

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: NEXVIAZYME
Status/Status Date:
REGISTERED
10/12/2021
Serial Number: 88318614
Filing Date: 2/27/2019
Registration Number: 6521238
Registration Date: 10/12/2021
Goods and Services: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 5/28/2019
Last Applicant/Owner:
GENZYME CORPORATION
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
REGISTERED
10/12/2021
Correspondent Search:
Karen Lim is a correspondent of NEXVIAZYME trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on